PointCare Technologies is a privately held expansion stage company whose core competency is the invention and development of groundbreaking methods in the field of cellular analysis.PointCare was founded in 2003 by Dr. Petra Krauledat and Dr. Peter Hansen. Their patented innovations in immunohematology, flow cytometry, and infectious disease diagnostics, have repeatedly set new standards for the tools employed in cellular research. Dr. Krauledat, who is PointCare's CEO, introduced the first commercial HIV test in Europe for Behringwerke and managed the development of the first Hepatitis C assay in the world for Johnson & Johnson's Ortho Diagnostics/Chiron joint venture. Dr. Peter Hansen, PointCare's technical founder and Chief Science Officer, holds 15 patents for innovations in flow cytometry, immunoassay technology, and nucleic acid detection. In 1980 Hansen co-invented the first automated flow cytometry system for CD4 counting in AIDS, which became the basis for all flow cytometry CD4 counting in use today. In 2010 the American Institute for Medical Biological Engineering inducted, into its College of Fellows recognizing his seminal contributions.